AbbVie has launched Love in Mind™, an educational initiative aimed at raising awareness of how migraine affects romantic relationships and emotional well-being. Based on a Harris Poll survey of 606 U.S. adults diagnosed with migraine conducted in September 2025, 89% of respondents said it is hard to feel present during an attack, 51% reported canceling or rescheduling a date (an average of eight times in the past year), and 78% admitted pushing through pain to maintain intimacy. The campaign features country music star Jessie James Decker sharing her personal migraine journey and offers resources at LoveInMind.com, while relationship expert Nedra Glover Tawwab provides guidance on communication and self-compassion strategies for patients and partners.

Migraine affects nearly 40 million Americans and represents a significant growth opportunity for AbbVie, which is uniquely positioned with three prescription treatments spanning acute and preventive care. By focusing on the emotional dimensions of the disease, Love in Mind™ seeks to deepen patient engagement and differentiate AbbVie’s portfolio in a crowded neurology market. Enhanced brand loyalty and improved patient-provider dialogue may drive greater uptake of existing therapies and pave the way for new product launches, supporting long-term revenue growth and reinforcing AbbVie’s leadership in migraine care.